New York City Taxotere Lawsuit Attorney

There’s no doubt that Taxotere (also known as docetaxel) saves lives. Since it was approved by the Food & Drug Administration (FDA) in 1995, it has been hailed as one of the safest and most effective weapons we have against certain types of cancer, including breast cancer and stomach cancer.

However, although the drug does a lot of good, for many years, Sanofi-Aventis did not properly warn consumers about some of the serious side effects of their chemotherapy drug, including permanent hair loss (alopecia). While temporary hair loss is often expected by patients receiving chemotherapy, many men and women were never told that there was a chance their hair would never return–even though the company was aware of the risk.

If you have suffered permanent hair loss due to taxotere treatments, you could be eligible to collect compensation through filing a defective drug lawsuit. The New York City personal injury lawyers at Meirowitz & Wasserberg, LLP can help you decide if you are eligible for punitive damages and compensation for:

  • Past and future medical costs, including therapy and medication.
  • Loss of wages or earning potential.
  • Mental anguish.
  • Lowered quality of life.

Taxotere & Permanent Hair Loss

Taxotere causes some temporary hair loss in most patients, but it can lead to permanent follicle  damage in a significant number of others. It is clear that the drug’s manufacturer, Sanofi-Aventis, knew this information as early as 2005, when it informed the European medical community of the risk. In 2012, the same warning was added to taxotere marketing in Canada. Here in the United States, patients weren’t warned about the possibility of permanent hair loss until 2015.

Sanofi-Aventis is there for being sued for:

  • Knowing that their drug caused permanent hair loss, but not alerting consumers.
  • Selling a defective drug without a proper warning label.
  • Failing to properly test their drug for side effects.
  • Caused patient’s emotional trauma and long-term diminishment of quality of life through their negligence.

There are currently almost 1,300 defective drug cases filed in the United States regarding taxotere and hair loss. The first bellwether cases will be held in 2018.

Facts About Taxotere

Generic name: Docetaxel

Uses: Chemotherapy

Treatments for: Breast cancer, head cancer, neck cancer, prostate cancer, stomach cancer, and some types of lung cancer.

Possible side effects: hair loss, permanent hair loss, shortness of breath, muscle pain, vomiting, future cancer.

Patented: 1986

FDA Approval: 1995

Manufacturer: Sanofi-Aventis

Application: Slow injection

Understand Your Taxotere Legal Options

If you suffered permanent hair loss after using taxotere before the warning was added in 2015, you may deserve compensation for your financial losses and emotional trauma. Join the hundreds of men and women who are demanding that Sanofi-Aventis take responsibility for their negligence and pay for their violation of the law.

At Meirowitz & Wasserberg, our attorneys have extensive knowledge and experience when it comes to dangerous drugs, defective medications, and medical product liability. We also deeply understand how defective drugs can alter the course of your life, even if they help as well as harm. We offer our potential clients free, confidential consultations. To learn more, please contact our offices by calling 212-897-1988 or filling out our short contact form